Targeting ODC as an Immunotherapeutic Target in STK11 (LKB1) Pathway-Deficient NSCLC (DFMO)
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Alliance for Clinical Trials in Oncology
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
University of Florida
Centre Leon Berard
Masonic Cancer Center, University of Minnesota
AHS Cancer Control Alberta
Weill Medical College of Cornell University
Weill Medical College of Cornell University
Cancer Research UK
Northwell Health
University of Florida
Insel Gruppe AG, University Hospital Bern
Optimal Health Research
Centre Leon Berard
Dushu Lake Hospital Affiliated to Soochow University
Sunnybrook Health Sciences Centre
Shanghai Minimally Invasive Surgery Center
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Northwestern University
Shanghai Jiao Tong University School of Medicine
Shenzhen Geno-Immune Medical Institute
Institut Paoli-Calmettes
Southern Europe New Drug Organization
Hokkaido Gastrointestinal Cancer Study Group
University of Vermont
Hokkaido Gastrointestinal Cancer Study Group